Topics
October 2016 | Cover Focus: New Developments
5-Year Results With a Retinal Prosthesis System
Patients with severe to profound RP are experiencing promising outcomes with the Argus II.
Lyndon da Cruz, MA, MD, PhD
July 31, 2026
Annexon Secures Up to $200 Million Credit Facility to Support Global Commercialization Plans
EyePoint Completes Enrollment in Phase 3 Duravyu Trials for DME Ahead of Schedule
July 30, 2026
Spanish Researchers Show Photoswitchable Drug Candidates Restore Vision-Related Behaviors in Retinal Degeneration Models
July 28, 2026
CHMP Backs Roche’s Susvimo for Wet AMD, European Commission Decision Pending
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Editorially independent content supported by advertising from Genentech
Free Print Subscription
Email Newsletter
Conference Calendar
